☆ 4.7 News Item

Osimertinib improves progression-free survival in NSCLC

LANCET ONCOLOGY (2018)

Get Full Text
Add to Collection

Journal

LANCET ONCOLOGY
Volume 19, Issue 1, Pages E10-E10

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S1470-2045(17)30893-8

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.